Document Detail

Cerebral infarction and antiphospholipid syndrome in children.
MedLine Citation:
PMID:  8856624     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To investigate the prevalence of antiphospholipid antibodies (aPL) in children with acute cerebral infarction. METHODS: The study was carried out in 10 consecutive patients during the first days of neurological symptoms. aPL detected as lupus anticoagulant or anticardiolipin antibodies (aCL) and natural anticoagulant proteins C, S, and antithrombin III were determined in all patients. RESULTS: Seven patients had acute cerebral infarctions associated with aCL; 4 of these patients had high serum aCL concentrations in 2 different determinations (antiphospholipid syndrome). Two patients had temporary protein C deficiency. In one patient with negative aCL, protein C, S, and antithrombin III determinations were not carried out. No patient had evidence of connective tissue disease or family history of hypercoagulable state. After followup of 15.7 months, no patient had recurrent infarction while taking aspirin. CONCLUSION: Our study demonstrates high prevalence of aCL in children who suffer acute cerebral infarction and our results suggest aspirin may be effective therapy to prevent recurrences.
V Baca; R Garcia-Ramirez; M Ramirez-Lacayo; L Marquez-Enriquez; I Martinez; C Lavalle
Related Documents :
25359094 - The prevalence of increased serum ige and aspergillus sensitization in patients with co...
19797184 - Silent cerebral infarcts in patients with pulmonary embolism and a patent foramen ovale...
3055834 - Italian cooperative study on giant intracranial aneurysms: 2. radiological data.
20386284 - Pharmacologic thromboprophylaxis is a risk factor for hemorrhage progression in a subse...
14978664 - Predictive factors in early arthritis: long-term follow-up.
9164684 - Radiosurgery for arteriovenous malformations: the university of toronto experience.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of rheumatology     Volume:  23     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  1996 Aug 
Date Detail:
Created Date:  1997-05-22     Completed Date:  1997-05-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  1428-31     Citation Subset:  IM    
Department of Immunology, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, Mexico City, Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Anticardiolipin / blood
Antiphospholipid Syndrome / complications*,  diagnosis,  drug therapy
Aspirin / therapeutic use
Biological Markers / analysis
Cerebral Infarction / complications*,  drug therapy
Child, Preschool
Magnetic Resonance Angiography
Magnetic Resonance Imaging
Prospective Studies
Protein C / analysis
Reg. No./Substance:
0/Antibodies, Anticardiolipin; 0/Biological Markers; 0/Protein C; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 ...
Next Document:  Synovial cyst as differential diagnosis of supraclavicular mass in rheumatoid arthritis.